OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
83
Results
Show all
Save search
Copy query
Show results for
Unknown
(82)
Genomic
(1)
Repository
dbGaP
(1)
Publication Date
Release Date
2015
(12)
2022
(10)
2016
(8)
2024
(7)
2023
(7)
2018
(7)
2019
(5)
2014
(5)
2021
(4)
2017
(4)
2013
(4)
2020
(3)
2010
(3)
2026
(1)
2025
(1)
2012
(1)
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain.
Not available
S-EPMC2919622
|
biostudies-literature
Cite
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
Not available
S-EPMC8738121
|
biostudies-literature
Cite
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
Not available
S-EPMC11140579
|
biostudies-literature
Cite
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.
Not available
S-EPMC4970462
|
biostudies-literature
Cite
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
Not available
S-EPMC9678104
|
biostudies-literature
Cite
Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.
Not available
S-EPMC5536893
|
biostudies-literature
Cite
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort.
Not available
S-EPMC11528207
|
biostudies-literature
Cite
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
Not available
S-EPMC8362593
|
biostudies-literature
Cite
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.
Not available
S-EPMC10189606
|
biostudies-literature
Cite
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.
Not available
S-EPMC11365761
|
biostudies-literature
Cite
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets